AWM
ZYME icon

AE Wealth Management’s Zymeworks ZYME Stock Holding History

AE Wealth Management’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-63,736
Closed -$551K – 2088
2023
Q2 		$551K Buy
+63,736
New +$571K ﹤0.01% 1340
2020
Q1 		– Sell
-5,348
Closed -$243K – 1294
2019
Q4 		$243K Buy
+5,348
New +$194K 0.01% 988

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

AE Wealth Management's ZYME Position: Q3 2023 in Review

AE Wealth Management sold out of Zymeworks (ZYME) in Q3 2023, closing a stake of 63,736 shares — an estimated $551K sold.

AE Wealth Management first reported a position in ZYME in Q4 2019 and held it in 2 quarters. The position peaked at $551K in Q2 2023. 139 funds tracked by Wall St. Rank hold ZYME as of Q3 2023.

  • AE Wealth Management reported no remaining Zymeworks position as of Q3 2023 after selling out during the quarter.
  • AE Wealth Management sold 63,736 Zymeworks shares in Q3 2023, an estimated $551K.
  • AE Wealth Management first reported a position in Zymeworks in Q4 2019 and held it in 2 quarters.
  • AE Wealth Management's Zymeworks position peaked at $551K in Q2 2023.
  • 139 funds tracked by Wall St. Rank held Zymeworks as of Q3 2023.

Based on AE Wealth Management's 13F filing for Q3 2023, filed 11 Oct 2023.